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After malaria and lymphatic filariasis, leishmaniasis is the third most
important vector-borne disease of humans; it is caused by several
Leishmania species, most of zoonotic concern.1 in veterinary medicine,
canine leishmaniosis caused by L infantum is of primary interest, because
dogs are the main reservoir of the parasite for humans, and management
of the canine disease may be challenging.2
Cats are naturally infected by the same Leishmania species that affect
dogs and humans in
tropical and subtropi-
cal areas worldwide:
L infantum in the
Mediterranean basin,
iran and Brazil; 
L mexicana in Texas,
USA; L braziliensis in
Brazil and French
Guiana; L amazo-




ity of cats has been confirmed by experimental studies [EBM grade
iii].11,12
Life cycle and transmission
Leishmania species are protozoan parasites, the natural history of which
involves two hosts: the phlebotomine sand fly and a vertebrate. The
vector harbours flagellated extracellular promastigote forms and
transmits them to a vertebrate host; there, the parasite changes into the
amastigote form that is able to survive and replicate in intracellular
vacuoles within macrophages. Haematophagous female sand flies
transmit the promastigotes or may take up amastigotes from an infected
vertebrate host.
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The European Advisory Board on Cat Diseases (ABCD) is
a body of experts in immunology, vaccinology and clinical
feline medicine that issues guidelines on prevention and
management of feline infectious diseases in Europe, 
for the benefit of the health and welfare of cats. The
guidelines are based on current scientific knowledge of
the diseases and available vaccines concerned.
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Overview: Leishmania infection is less known 
in cats than in dogs and humans; felids were
traditionally considered a resistant species, 
and canids as the main reservoir. Only sporadic
cases of feline disease have been reported
worldwide, mainly caused by L infantum.
Epidemiological investigations have confirmed,
however, that feline infections are not rare 
and that disease occurrence might be
underestimated in endemic areas. 
Infection: Cats are infected by the same
Leishmania species that infect dogs and humans
in tropical and subtropical areas worldwide.
Sand fly vectors take blood meals from cats and
are competent vectors for L infantum, as shown
experimentally.
Disease signs: Skin lesions (ulcerative, crusty,
nodular or scaly dermatitis) are the most
frequent clinical manifestations and sometimes
the only findings on physical examination.
Lymph node enlargement, weight loss, ocular
involvement (nodular blepharitis, uveitis,
panophthalmitis), decreased appetite, chronic
gingivostomatitis and lethargy are the most
frequent non-cutaneous findings, alone or in
combination.
Diagnosis: Direct confirmation can be obtained
by cytology, histology, isolation or polymerase
chain reaction (PCR) on samples of skin, lymph
nodes, blood or any affected tissue. Serology
using a validated immunofluorescence test,
ELISA, direct agglutination or Western blot has
been used to assess infection frequencies.
Disease management: Little information is
available about treatment with follow-up reports.
Long-term administration of allopurinol (10–20
mg/kg q12h or q24h) is usually clinical effective.
Vaccines are licensed for dogs only. 
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There is no evidence that ticks and fleas are
involved in natural Leishmania transmission.1,2
The risk of transmission in the absence of sand
flies is negligible, but transplacental infection
occurs as a rare event in both dogs and
humans.1,2 Venereal transmission is a potential
means of infection.13 other types of direct
transmission have been suggested to explain
the spread of the infection among kennel dogs
in the USA in the absence of sand fly 
vectors.1,2 The risk of transmission by blood
transfusion is important for humans and dogs
in endemic areas.1,2,14
Many studies have demonstrated that sand
flies take blood meals from cats; experi -
mentally, sand flies have been found to be
competent vectors for L infantum in cats 
[EBM grade iii].15,16
Epidemiology
Leishmaniosis caused by L infantum is an
emerging disease globally.1,2 Using molecular
diagnostic techniques on dogs in endemic areas,
it was shown that the prevalence of the infection
is much higher than that of the disease.17 The
same is true for people: in some endemic areas,
latent infections approach 30% of the
population, based on a positive leishmanin skin
test.14 Leishmaniosis in cats is sporadically
reported worldwide, usually from the same
areas where the disease occurs in dogs or
humans.3 Cases have been seen in Switzerland,
in cats imported from Spain; increased pet
movement throughout Europe will lead to more
disease, including in non-endemic areas [EBM
grade iV].18
Epidemiological studies have been per-
formed during the past 15 years in endemic
areas using serological (immunofluorescence,
ELiSA, Western blot, direct agglutination)
and/or parasitological methods (cytology,
immunohistochemistry, PCR). The rates of
infection vary widely, which may be due to
the methodology used, the geographic area
and population under study. Positive blood
PCR rates range between 0.43 and 61% of the
population tested, and antibody prevalence
between 3 and 59%.3
Pathogenesis
disease development is influenced by
immunological factors, which are linked to the
complex genetic background of the hosts, as
demonstrated by studies in laboratory animals,
dogs and humans.2 in people, L infantum can
induce anything between a local skin lesion
and a severe visceral disease. The latter form
is the typical presentation in immune-
incompetent patients.14 in dogs, leishmaniosis
is a multisystemic disease with a wide
REV IEW / ABCD guidelines on leishmaniosis
spectrum of severity that reflects the balance
between the protective cell-mediated and the
non-protective humoral immune response. in
both humans and dogs there is a dynamic
range from subclinical infection to self-limiting
mild and non-self-limiting severe disease.1,2
in all host species, macrophages play a 
central role in the control of the infection.
Cytokines such as iFN-γ, iL-2 and TNF-α,
secreted by activated T cells, stimulate intra-
cellular killing of Leishmania amastigotes by
macrophages. The presence of Leishmania-
infected macrophages is usually associated
with a granulomatous inflammatory reac -
tion.2 Lymphoid hyperplasia is also common.
A massive antibody response is responsible
for immune complex deposition in the kidney,
with glomerulonephritis and subsequent
renal failure.1,2
Histopathology of feline skin lesions mainly
shows a diffuse granulomatous dermatitis
with macrophages containing many
Leishmania parasites, or a granulomatous 
perifolliculitis and lichenoid tissue reaction/
interface dermatitis, with a lower parasite
load.19,20 Granulomatous inflammation has
also been seen in the liver and kidney.20
Epidemiological studies have shown that
Leishmania infection of cats is more common
than the associated disease; cats may remain
PCR and antibody positive for a long time.3
Cats may be more resistant than dogs to
developing disease.
Clinical signs
Canine leishmaniosis is usually chronic and
progressive, with an incubation period lasting
for months or even years. Any tissue or organ
may be involved, but skin lesions are most
suggestive, and renal disease is most important
prognostically.1
Feline leishmaniosis caused by L infantum
has been documented mainly in the past 20
years in Europe and Brazil.3 Cases have been
reported in cats of all ages, almost all domes-
tic shorthair, with no gender predilection.
Skin lesions are the most frequent clinical
manifestation, and sometimes the only find-
ing on physical examination. Ulcerative,
crusty, nodular or scaly dermatitis is found
mainly on the head and neck (Figures 1 and
2), less often on the trunk and legs. Pruritus is
usually absent; alopecia or a poor coat condi-
tion are reported. Lymph node enlargement,
weight loss, ocular involvement (nodular ble-
pharitis, uveitis, panophthalmitis), decreased
appetite, chronic gingivostomatitis and lethar-
gy are the most frequent non-cutaneous find-
ings. dehydration, pale mucous membranes,
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nasal discharge, recurrent abortion and dysp-
noea are also found, although less often.
information on clinicopathological abnor-
malities is scarce; in a few cases followed up
until death or euthanasia, glomerular disease
and chronic renal failure have been seen to
develop [EBM grade iV].21
data from complete blood counts and
serum protein electrophoresis are available
but the results may have been influenced by
concurrent disease as well as retroviral infec-
tion. Various haematological abnormalities
have been described in three cats suffering
from pancytopenia; in one of them, a retro-
virus-negative patient with myelofibrosis, 
4% of the circulating neutrophils contained
Leishmania parasites.22 Hyperglobulinaemia
and gammopathy are found in most investi-
gated cases [EBM grade iii].3
Immunity
Leishmania immunity is complex. in the dog, 
a susceptible species, protective immunity
against L infantum is Cd4 T cell mediated, 
and the release of gamma-interferon, iL2 
and TNF-α is associated with anti-Leishmania
activation of macrophages. A combination of
high antibody levels and a reduced cellular,
mixed Th1 and Th2 response is found in dogs
developing the disease.1,2
All sick cats possess specific antibodies, and
hyperglobulinaemia is often found. As report-
ed for dogs, Leishmania PCR-positive healthy
cats may be seronegative for anti-Leishmania
antibodies.3,23
infection experiments with L braziliensis have
shown that the development of skin lesions
precedes antibody appearance, and serocon-
version occurs when the lesions are healing.12
An association between feline immunodefi-
ciency virus (FiV) and L infantum infections
was found in endemic areas. Most cats devel-
oping clinical signs are suspected to have an
Figure 1 L infantum-associated ulcerative dermatitis in a cat.
Courtesy of Maria Grazia Pennisi Figure 2 L infantum-associated haemorrhagic nodule in a cat. Courtesy of Maria Grazia Pennisi
Figure 3 Lymph node smear
from a cat, showing
Leishmania amastigotes in 
a macrophage (MG-G stain;
x64 objective). Courtesy of
Maria Grazia Pennisi
impaired immune system because of concur-
rent FiV infection, FiV plus feline leukaemia
virus (FeLV) infection, cancer (squamous cell
carcinoma), diabetes mellitus, autoimmune
disease (pemphigus foliaceus), and treatment
with cortico steroids or other immunosuppres-
sive drugs [EBM grade iV].23–25
Diagnosis
The diagnosis can be accomplished by
parasitological (cytology, histology, PCR,
isolation) and serological methods
(immunofluorescence test, ELiSA, direct
agglutination, Western blot). in most feline
cases where cytology, isolation and PCR were
performed, they confirmed the diagnosis
obtained using lymph node, skin, bone
marrow or blood samples (Figure 3). ocular
disease caused by L infantum was diagnosed by
histology after enucleation of the affected eye.
on post-mortem examination, parasitological
evidence of infection was also obtained from
samples of spleen, liver, kidney, pancreas 
and gastrointestinal organs.3 immunohisto -
chemistry has been used on skin biopsies.19,20
Serological tests for leishmaniosis are not
commercially available. Recently, immuno -
fluorescence testing has been validated for use
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Treatment
The available information on treatment is
mostly based on single case reports, not always
with an appropriate follow-up (EBM grade
iV).3 Long-term administration of allopurinol
(10–20 mg/kg q12h or q24h) is usually
clinically effective, even in FiV-positive cats. 
However, the infection is not cleared and
clinical signs may recur after stopping therapy,
as is the case in dogs.3,26 Meglumine anti -
moniate (5–50 mg/kg or 375 mg/cat q24h SC
or iM under different protocols), used for
therapy in four cases, produced a good clinical
response [EBM grade iV].3 Surgical excision of
nodules performed in two cats was followed
by recurrence.18,27
Prevention
information is not available on the prevention
of feline leishmaniosis. in dogs, the disease is
prevented by means of application of repellent
agents against sand flies and, more recently,
also by vaccination.1
Leishmania species reported in cats are of zoonotic
concern but no information is available on the risk
associated for owners of infected cats. Vectorial
transmission is considered the principal route for 
L infantum and dogs are considered the main
peridomestic reservoir. Only one study, performed in Iran,
has found that owners of infected dogs have a higher risk
for leishmaniosis caused by L infantum.28
Zoono t i c  r i s k
Zoonosis
The Leishmania species




for grading the level
of evidence of
various statements
within this article is
described on 
page 533 of this
Special Issue.
< Cats are naturally infected by the same Leishmania species as dogs and humans 
in tropical and subtropical areas worldwide.
< Sand fly vectors take blood meals from cats and are competent vectors for L infantum.
< Leishmaniosis occurs sporadically worldwide in cats, usually in the same areas where
dogs or humans are affected, or in cats imported from these areas.
< The rates of infection vary in cats from endemic areas, dependent on the diagnostic
method, geographic area and population under study.
< Histology of the skin, liver and kidney shows a granulomatous inflammation.
< Skin lesions (ulcerative, crusty, nodular or scaly dermatitis) are the most frequent clinical
manifestations and sometimes the only findings on physical examination.
< Lymph node enlargement, weight loss, ocular involvement (nodular blepharitis, uveitis,
panophthalmitis), decreased appetite, chronic gingivostomatitis and lethargy are the most
frequent non-cutaneous findings.
< Glomerular disease and chronic renal failure are observed in followed-up cases. 
< An association between FIV and L infantum infections is found in endemic areas.
< Cytology, histology, isolation or PCR on samples of skin, lymph node, blood or any
affected tissue are useful for direct diagnosis.
< Serology using a validated immunofluorescence test, ELISA, direct agglutination 
or Western blot has been used to assess infection frequencies.
< Long-term administration of allopurinol (10–20 mg/kg q12h or q24h) is usually 
clinically effective.
< Apart from vector control, no preventive measure is known for cats; 
vaccines are licensed for dogs only. 
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